Plasma sex steroid hormones and breast cancer risk in Chinese women
Open Access
- 21 February 2003
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 105 (1) , 92-97
- https://doi.org/10.1002/ijc.11034
Abstract
Estrogens regulate the growth and differentiation of mammary cells and play an important role in the development of breast cancer. High circulating levels of estrogens are associated with increased risk of breast cancer in Caucasian women. Because Asian women have low estrogens in the circulation compared with their Caucasian counterparts, the effect of estrogens on breast cancer risk in populations with low circulating estrogens remains to be elucidated. We conducted a population‐based case‐control study in China to evaluate the association of sex steroid hormones with breast cancer risk in Chinese women. Our study included 300 incident cases with primary breast cancer and 300 age‐ and menopausal status‐matched healthy controls randomly selected from the general population in Shanghai. Fasting blood samples were collected from cases prior to any treatment and from their matched controls. Commercial immunoassays were used to measure plasma concentrations of estradiol, estrone, estrone sulfate, testosterone, progesterone, dehydroepiandrosteindian sulfate (DHEA‐S) and steroid hormone‐binding globulin (SHBG). Conditional logistic regression analysis was performed to examine the association between steroid hormones and breast cancer risk. The results showed that breast cancer risk was elevated with increasing levels of estrone and testosterone (p for trend < 0.05) but not with DHEA‐S, estradiol, estrone sulfate, progesterone or SHBG. The estimated relative risks between upper and lower tertiles were 2.07 (95% confidence interval [CI] 0.97–4.41) for estrone in postmenopausal women, 2.01 (95% CI 0.96–4.21) for testosterone in premenopausal women, and 2.40 (95% CI 1.11–5.21) for testosterone in postmenopausal women, after adjusting for age at first live birth, waist‐to‐hip ratio, total calorie intake, a history of fibroadenoma, a family history of breast cancer and SHBG. These results, in general, are consistent with the findings in Caucasian women and indicate that high sex steroid hormones in the circulation, both androgen and estrogen, are associated with increased risk of breast cancer even in populations with relatively low sex hormones.Keywords
This publication has 34 references indexed in Scilit:
- Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer ElementsJournal of Biological Chemistry, 2001
- Testosterone-Induced Growth of S115 Mouse Mammary Tumor Cells Is Dependent on Heparan SulfateExperimental Cell Research, 2001
- Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast CancerAnnals of Internal Medicine, 1999
- Serum Sex Hormone Levels After Menopause and Subsequent Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Epidemiology and Prevention of Breast CancerAnnual Review of Public Health, 1996
- Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylationMolecular Endocrinology, 1995
- A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1995
- Endogenous steroid hormones and local aromatase activity in the breastThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Relation between Risk of Breast Cancer and Biological Availability of Estradiol in the Blood: Prospective Study in GuernseyAnnals of the New York Academy of Sciences, 1986
- Relation of the neuroendocrine system to the development and growth of experimental mammary tumorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980